To address this possibility more conclusively, we used mRNA expression data for 72 normal renal epithelial cells and 531 clear cell RCC tumors from the TCGA database to assess the expression changes and possible association of tumor Trem1 to patient outcomes. This evidence concerns the gene TREM1 and neoplasm.